Randomized phase II trial of olaparib + pembrolizumab versus olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2+) mutations: SWOG S2001 Meeting Abstract
| Authors: | Chung, V.; Guthrie, K. A.; Pishvaian, M. J.; Lowy, A. M.; Chiorean, E. G.; Duong, M. T.; O'Reilly, E. M.; Philip, P. A. |
| Abstract Title: | Randomized phase II trial of olaparib + pembrolizumab versus olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2+) mutations: SWOG S2001 |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800048 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.TPS447 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS447 -- Source: Wos |
